Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
26
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Arhaus
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Consumer Preference Will Reshape US Premium Home Environments
Key Takeaways Focus on premium, customizable, and sustainable furnishings supports revenue growth, pricing power, and showroom expansion in both established and new markets. Investments in omnichannel platforms and supply chain efficiency drive higher margins and position Arhaus for continued market share gains.
View narrative
US$12.08
FV
2.7% overvalued
intrinsic discount
6.71%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
ASTE
Aster DM Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Mergers And Expansion Will Unlock India's Healthcare Potential
Key Takeaways Merger with QCIL and targeted expansions will strengthen market position, revenue growth, and access to high-demand regions and specialties. Digital adoption, operational efficiencies, and specialty focus are set to enhance margins, profitability, and long-term returns.
View narrative
₹659.00
FV
8.6% undervalued
intrinsic discount
20.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
3 days ago
author updated this narrative
Century Aluminum
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Mt Holly Restart And US Smelter Will Drive Aluminum Expansion
Key Takeaways Expansion of U.S. production and operational efficiency improvements position the company to benefit from rising demand and favorable market conditions. Government incentives and strong end-market trends support revenue growth, margin expansion, and enhanced financial flexibility for future initiatives.
View narrative
US$25.50
FV
12.9% undervalued
intrinsic discount
6.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
3 days ago
author updated this narrative
TruBridge
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
AI And India Hub Will Boost Future Healthcare Efficiency
Key Takeaways AI-driven solutions and strategic partnerships are strengthening TruBridge's differentiation, supporting market expansion and long-term growth in digital healthcare. Operational efficiencies via offshoring and rising demand for outsourced billing position TruBridge for sustained cost savings and recurring revenue streams.
View narrative
US$24.75
FV
17.3% undervalued
intrinsic discount
3.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
8 days ago
author updated this narrative
Comstock
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Solar Recycling And Sustainable Fuels Will Open Global Markets
Key Takeaways Accelerating growth in recycling and sustainable fuels, backed by integrated IP, partnerships, and global policy alignment, strengthens Comstock's competitive position and margin sustainability. Expansion into high-value renewable markets and scalable operations positions Comstock for continued revenue growth and outperformance as demand for clean energy rises.
View narrative
US$4.00
FV
38.3% undervalued
intrinsic discount
243.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
Updated
narrative
Toyota Motor
AN
AnalystConsensusTarget
Consensus Narrative from 19 Analysts
Recovering Production And Battery Investments Will Boost Future Profitability
Key Takeaways Efforts to recover production and reduce incentives aim to sustain and grow Toyota's profitability amid competitive markets. Investing in internal battery production and operational efficiency seeks to bolster revenue and margins in the electrified vehicle market.
View narrative
JP¥3.00k
FV
1.8% undervalued
intrinsic discount
2.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
39
users have followed this narrative
16 days ago
author updated this narrative
PTC Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Broad Approvals Will Elevate Rare Disease Markets Despite Setbacks
Key Takeaways Broad approvals and strong launch strategy for Sephience position the company to accelerate growth and improve profitability in rare disease markets worldwide. Advancing pipeline and strategic capital moves enhance revenue stability, earnings visibility, and highlight potential undervaluation versus long-term growth prospects.
View narrative
US$68.31
FV
26.0% undervalued
intrinsic discount
-9.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
9 days ago
author updated this narrative
Sensient Technologies
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
US Regulation And APAC Demand Will Unlock Natural Colors Potential
Key Takeaways Regulatory changes and Sensient's investments in natural colors position it for strong growth and margin gains driven by clean-label demand. Expansion in global capacity and emerging markets supports sustainable revenue growth and increasing operating leverage.
View narrative
US$121.67
FV
5.7% undervalued
intrinsic discount
6.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
MarketAxess Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Emerging Markets And Electronic Trading Will Drive Future Success
Key Takeaways Expansion into new markets and digital asset classes is broadening MarketAxess's reach and potential for sustained revenue and earnings growth. Strategic technology investments and regulatory trends are driving increased electronic trading, boosting operating leverage and supporting higher long-term margins.
View narrative
US$218.83
FV
13.8% undervalued
intrinsic discount
7.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies